Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose Constraints

Rossi, 2014, Therapeutic options for the management of pancreatic cancer, World J Gastroenterol, 20, 1142, 10.3748/wjg.v20.i32.11142 Herman, 2015, Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma, Cancer, 121, 1128, 10.1002/cncr.29161 Wild, 2016, Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2015.11.026 Mahadevan, 2011, Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer, Int J Radiat Oncol Biol Phys, 81, e615, 10.1016/j.ijrobp.2011.04.045 Chang, 2009, Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas, Cancer, 115, 665, 10.1002/cncr.24059 LaCouture, 2016, Small bowel dose tolerance for stereotactic body radiation therapy, Semin Radiat Oncol, 26, 157, 10.1016/j.semradonc.2015.11.009 Murphy, 2010, A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer, Int J Radiat Oncol Biol Phys, 78, 1420, 10.1016/j.ijrobp.2009.09.075 Lyman, 1985, Complication probability as assessed from dose-volume histograms, Radiat Res, 104, S13, 10.2307/3576626 Kutcher, 1989, Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method, Int J Radiat Oncol Biol Phys, 16, 1623, 10.1016/0360-3016(89)90972-3 Niemierko, 1997, Reporting and analyzing dose distributions: A concept of equivalent uniform dose, Med Phys, 24, 103, 10.1118/1.598063 Bae, 2012, Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies, Int J Radiat Oncol Biol Phys, 84, e469, 10.1016/j.ijrobp.2012.06.005 Bae, 2013, Feasibility and efficacy of stereotactic ablative radiotherapy for Barcelona Clinic Liver Cancer-C stage hepatocellular carcinoma, J Korean Med Sci, 28, 213, 10.3346/jkms.2013.28.2.213 Prior, 2014, Consolidating duodenal and small bowel toxicity data via isoeffective dose calculations based on compiled clinical data, Pract Radiat Oncol, 4, e125, 10.1016/j.prro.2013.05.003 Brunner, 2015, SBRT in pancreatic cancer: What is the therapeutic window?, Radiother Oncol, 114, 109, 10.1016/j.radonc.2014.10.015 Chuong, 2013, Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated, Int J Radiat Oncol Biol Phys, 86, 516, 10.1016/j.ijrobp.2013.02.022 Yang, 2015, Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancer, Med Dosim, Spring, 40, 47, 10.1016/j.meddos.2014.09.001 Tomé, 2000, Selective boosting of tumor subvolumes, Int J Radiat Oncol Biol Phys, 48, 593, 10.1016/S0360-3016(00)00666-0 Dose Volume Histogram analysis of Stereotactic Body Radiotherapy treatment of primary pancreatic cancer: setting new dose volume constraints” Goldsmith C, Price P, Cross T et al, ECCO 18 Abstracts book. ECC 2015 abstract #2273, accessible at http://poster-submission.com/ecc2015/visitors/carousel Fowler, 1958, Letter: Dose-rate factors in integral dose estimations, Br J Radiol, 31, 316, 10.1259/0007-1285-31-366-316 Douglas, 1975, Letter: Fractionation schedules and a quadratic dose-effect relationship, Br J Radiol, 48, 502, 10.1259/0007-1285-48-570-502 Barendsen, 1982, Dose fractionation, dose rate and iso-effect relationships for normal tissue responses, Int J Radiat Oncol Biol Phys, 8, 1981, 10.1016/0360-3016(82)90459-X Ryu S, Gerszten P, Yin F, et al: Phase II/III study of image-guided radiosurgery/SBRT for localized spine metastasis. Radiation therapy oncology group 0631. Available at: http://www.rtog.org. Benedict, 2010, Stereotactic body radiation therapy: The report of AAPM task group 101, Med Phys, 37, 4078, 10.1118/1.3438081 Timmerman, 2008, An overview of hypofractionation and introduction to this issue of seminars in radiation oncology, Semin Radiat Oncol, 18, 215, 10.1016/j.semradonc.2008.04.001 National Cancer Institute. Common terminology criteria for adverse events, version 3.0.2006. Available at: http://ctep.cancer.gov/reporting/ctc.html. Fischer, 1977, Dose response relationships in radiotherapy: Applications of logistic regression models, Int J Radiat Oncol Biol Phys, 2, 773, 10.1016/0360-3016(77)90063-3 Schultheiss, 1983, Models in radiotherapy: Volume effects, Med Phys, 10, 410, 10.1118/1.595312 Herring, 1980, Methods for extracting dose response curves from radiation therapy data, I: A unified approach, Int J Radiat Oncol Biol Phys, 6, 225, 10.1016/0360-3016(80)90042-5 Jackson, 1995, Analysis of clinical complication data for radiation hepatitis using a parallel architecture model, Int J Radiat Oncol Biol Phys, 31, 883, 10.1016/0360-3016(94)00471-4 Cox, 1989 Levegrün, 2001, Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiologic parameters for tumors from clinical data, Int J Radiat Oncol Biol Phys, 51, 1064, 10.1016/S0360-3016(01)01731-X Asbell, 2016, Introduction and clinical overview of the DVH Risk Map, Semin Radiat Oncol, 26, 89, 10.1016/j.semradonc.2015.11.005 Dieterich, 2011, The CyberKnife in clinical use: Current roles, future expectations, Front Radiat Ther Oncol, 43, 181, 10.1159/000322423 Brown, 2007, CyberKnife radiosurgery for stage I lung cancer: Results at 36 months, Clin Lung Cancer, 8, 488, 10.3816/CLC.2007.n.033 Kudchadker, 2009, Effectiveness of using fewer implanted fiducial markers for prostate target alignment, Int J Radiat Oncol Biol Phys, 74, 1283, 10.1016/j.ijrobp.2009.02.033 Subedi, 2015, Factors that may determine the targeting accuracy of image-guided radiosurgery, Med Phys, 42, 6004, 10.1118/1.4930961 Taylor, 2016, The importance of Quasi-4D path-integrated dose accumulation for more accurate risk estimation in stereotactic liver radiotherapy, Technol Cancer Res Treat, 10.1177/1533034615584120 Pan, 2004, 4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT, Med Phys, 31, 333, 10.1118/1.1639993 Cai, 2015, 3D delivered dose assessment using a 4DCT-based motion model, Med Phys, 42, 2897, 10.1118/1.4921041 Huguet, 2015, Modeling pancreatic tumor motion using 4-dimensional computed tomography and surrogate markers, Int J Radiat Oncol Biol Phys, 91, 579, 10.1016/j.ijrobp.2014.10.058 Descovich, 2015, Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: Insights from lung tumor patients treated with robotic radiosurgery, Med Phys, 42, 1280, 10.1118/1.4907956 Minn, 2009, Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment, Am J Clin Oncol, 32, 364, 10.1097/COC.0b013e31818da9e0 Chan, 2013, Quantifying variability of intrafractional target motion in stereotactic body radiotherapy for lung cancers, J Appl Clin Med Phys, 14, 140, 10.1120/jacmp.v14i5.4319 Winter, 2015, Accuracy of robotic radiosurgical liver treatment throughout the respiratory cycle, Int J Radiat Oncol Biol Phys, 93, 916, 10.1016/j.ijrobp.2015.08.031 Saito, 2009, Introducing sitetrack: Continuous patient motion monitoring during stereotactic radiotherapy for the head, Neurosurgery, 64, A110, 10.1227/01.NEU.0000340794.30989.8C Wulf, 2001, Stereotactic radiotherapy of targets in the lung and liver, Strahlenther Onkol, 177, 55 Kopek, 2010, Stereotactic body radiotherapy for unresectable cholangiocarcinoma, Radiother Oncol, 94, 47, 10.1016/j.radonc.2009.11.004 Mahadevan, 2010, Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 78, 735, 10.1016/j.ijrobp.2009.08.046 Barney, 2012, Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors, Am J Clin Oncol, 35, 537, 10.1097/COC.0b013e31821f876a Koong, 2004, Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 58, 1017, 10.1016/j.ijrobp.2003.11.004 Bijl, 2003, Unexpected changes of rat cervical spinal cord tolerance caused by inhomogeneous dose distributions, Int J Radiat Oncol Biol Phys, 57, 274, 10.1016/S0360-3016(03)00529-7 Philippens, 2009, Bath and shower effect in spinal cord: The effect of time interval, Int J Radiat Oncol Biol Phys, 73, 514, 10.1016/j.ijrobp.2008.09.028 van Luijk, 2009, Bath and shower effects in the rat parotid gland explain increased relative risk of parotid gland dysfunction after intensity-modulated radiotherapy, Int J Radiat Oncol Biol Phys, 74, 1002, 10.1016/j.ijrobp.2009.03.039